Abiopharma

Supplementary report to the meeting convening notice report to be held on 15.7.26

La division hématologique phare de BeOne Medicines ouvre la voie à une nouvelle ère d’innovation dans le traitement des cancers à cellules B lors du congrès EHA 2026

Trustee report for the company’s BONDS Series 1 for 2025, Mishmeret

Invitation to a special meeting on 22.7.26 – arrangement for delimiting activity with BIG Shopping Centers – voting ballot

Register of shareholders, changes and capital status – exercise of employee warrants

Tender for issuance of BONDS (Series 6) to classified investors on 15.6.26

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Change in holdings of interested parties/officers

IQM任命Vanguard董事、前Deloitte Digital全球負責人Barbara Venneman為董事會成員

IQM任命Vanguard董事、前Deloitte Digital全球负责人Barbara Venneman为董事会成员